Article info

Download PDFPDF

Original research
Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunity

Authors

  1. Correspondence to Dr Adam E Snook; adam.snook{at}jefferson.edu
View Full Text

Citation

Flickinger Jr JC, Singh J, Carlson R, et al
Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunity

Publication history

  • Accepted July 21, 2020
  • First published August 20, 2020.
Online issue publication 
August 20, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.